MDA5阳性皮肌炎中抗MDA5 IgG亚类的分布
该研究在36例抗MDA5抗体阳性的DM/CADM患者中检测抗MDA5的IgG、IgA、IgM同种型及IgG亚类,分析其与ILD风险和生存的关系。结果显示抗MDA5 IgG1阳性者急性间质性肺炎发生率、死亡率和血清铁蛋白显著更高,抗MDA5 IgG1联合IgG4预测死亡特异性更优。
要点
- 抗MDA5 IgG和IgA是主要同种型,阳性率分别为100%和97%。
- 抗MDA5 IgG1阳性者急性间质性肺炎、死亡率和铁蛋白显著更高。
- 抗MDA5 IgG1联合IgG4预测死亡特异性达87.5%。
核心结论
- IgA和IgG是抗MDA5抗体的主要同种型。
- 抗MDA5 IgG1是MDA5 IgG亚类的主要成分。
- 抗MDA5 IgG1和IgG4可能作为预测DM-ILD死亡的有用生物标志物。
研究设计与样本
- 研究纳入36例抗MDA5抗体阳性的DM/CADM患者,采用ELISA检测血清抗MDA5同种型及IgG亚类并结合实验室指标和累积生存分析。
主要发现
- 抗MDA5 IgG、IgA和IgM阳性率分别为100%、97%和6%。
- 抗MDA5 IgG1、IgG2、IgG3和IgG4阳性率分别为72%、25%、0%和28%。
- 抗MDA5 IgG1阳性患者较阴性患者急性间质性肺炎发生率、死亡率和血清铁蛋白显著更高(P分别为0.0027、0.015、0.0011)。
关键数值与推荐
- 抗MDA5 IgG1预测死亡的敏感性为100%,特异性为41.7%。
- 抗MDA5 IgG1联合IgG4预测死亡的特异性为87.5%。
临床怎么用
- 对MDA5阳性DM/CADM患者可检测抗MDA5 IgG1和IgG4亚类以辅助评估死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The anti-melanoma differentiation-associated gene 5 (MDA5) antibody is the main predictor of interstitial lung disease (ILD) in DM and clinically amyopathic DM (CADM). Nevertheless, a subset of MDA5+ patients have a favourable prognosis. We aimed to determine the possibility of using anti-MDA5 antibody isotypes and IgG subclasses for evaluating ILD risk. METHODS: The isotypes (IgG, IgA and IgM) of anti-MDA5 were detected in serum samples of 36 anti-MDA5+ patients with DM/CADM using ELISA. IgG subclasses of anti-MDA5 antibodies were further investigated. Laboratory findings and cumulative survival were analysed based on the isotypes of anti-MDA5 and subclasses of anti-MDA5 IgG. RESULTS: Among the MDA5+ patients with DM/CADM, the positive rates of anti-MDA5 IgG, IgA and IgM were 100, 97 and 6%, respectively. The positive rates of anti-MDA5 IgG1, IgG2, IgG3 and IgG4 were 72, 25, 0 and 28%, respectively. The incidence of acute interstitial pneumonia, mortality rate and serum ferritin were significantly higher in anti-MDA5 IgG1+ patients than in anti-MDA5 IgG1- patients with DM/CADM (P = 0.0027, 0.015, 0.0011, respectively). The sensitivity and specificity of anti-MDA5 IgG1 for predicting mortality were 100 and 41.7%, respectively. A combination of anti-MDA5 IgG1 and IgG4 for predicting mortality yielded better specificity (87.5%). CONCLUSION: IgA and IgG are the primary anti-MDA5 antibody isotypes. Anti-MDA5 IgG1 is the primary component of MDA5 IgG subclasses and anti-MDA5 IgG1 and IgG4 might serve as useful biomarkers for predicting mortality in DM-ILD.
引用
- Chen M, Zhao Q, Diao L, et al. Distribution of anti-melanoma differentiation associated gene 5 (MDA5) IgG subclasses in MDA5+ dermatomyositis. Rheumatology (Oxford). 2021. PMID: 33742662. doi:10.1093/rheumatology/keab268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。